State Street Corporation has appointed healthcare product producer Covidien chairman José (Joe) E. Almeida to its board of directors.
With more than 18 years leadership experience at the large public company, Almeida will bring a valuable knowledge of innovation and competition to the financial services research group, Joseph L. Hooley, chairman, president and chief executive officer of State Street Corporation, said.
Almeida joined Covidien in 1995 and has served as chairman of the company's board of directors since March 2012.
He has also previously held senior roles at Greatbatch Technologies, Inc., American Home Products' Acufex Microsurgical division and Johnson & Johnson's professional products division.
Almeida is also on the board of directors at Advanced Medical Technology Association (AdvaMed) and Partners in Health.
Australian Ethical has named its new head of equities, who previously spent 12 years at Perpetual.
The country’s sovereign wealth fund has unveiled a flurry of changes to its leadership team, including the appointment of a key executive role.
With Damian Graham stepping into a new capacity within the $190 billion super fund ahead of his retirement, a global search is set to commence for his replacement.
Cbus has swiftly promoted Leigh Gavin to chief investment officer only months after naming him deputy, as the fund works towards growing in size and bringing its investment expertise in-house.